Recipient obesity and outcomes after kidney transplantation: a systematic review and meta-analysis CJ Hill, AE Courtney, CR Cardwell, AP Maxwell, G Lucarelli, M Veroux, ... Nephrology Dialysis Transplantation 30 (8), 1403-1411, 2015 | 206 | 2015 |
Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage G Castellano, R Melchiorre, A Loverre, P Ditonno, V Montinaro, M Rossini, ... The American journal of pathology 176 (4), 1648-1659, 2010 | 206 | 2010 |
Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma G Lucarelli, V Galleggiante, M Rutigliano, F Sanguedolce, S Cagiano, ... Oncotarget 6 (15), 13371, 2015 | 184 | 2015 |
Metabolomic insights into pathophysiological mechanisms and biomarker discovery in clear cell renal cell carcinoma G Lucarelli, D Loizzo, R Franzin, S Battaglia, M Ferro, F Cantiello, ... Expert review of molecular diagnostics 19 (5), 397-407, 2019 | 164 | 2019 |
Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial … G Lucarelli, M Rutigliano, F Sallustio, D Ribatti, A Giglio, ML Signorile, ... Aging (Albany NY) 10 (12), 3957, 2018 | 159 | 2018 |
Patient and partner satisfaction after AMS inflatable penile prosthesis implant C Bettocchi, F Palumbo, M Spilotros, G Lucarelli, S Palazzo, M Battaglia, ... The journal of sexual medicine 7 (1_Part_1), 304-309, 2010 | 139 | 2010 |
The glucose and lipid metabolism reprogramming is grade-dependent in clear cell renal cell carcinoma primary cultures and is targetable to modulate cell viability and proliferation C Bianchi, C Meregalli, S Bombelli, V Di Stefano, F Salerno, B Torsello, ... Oncotarget 8 (69), 113502, 2017 | 124 | 2017 |
Endothelial-to-mesenchymal transition and renal fibrosis in ischaemia/reperfusion injury are mediated by complement anaphylatoxins and Akt pathway C Curci, G Castellano, A Stasi, C Divella, A Loverre, M Gigante, S Simone, ... Nephrology Dialysis Transplantation 29 (4), 799-808, 2014 | 119 | 2014 |
Artificial Intelligence and Machine Learning in Prostate Cancer Patient Management—Current Trends and Future Perspectives OS Tătaru, MD Vartolomei, JJ Rassweiler, O Virgil, G Lucarelli, F Porpiglia, ... Diagnostics 11 (2), 354, 2021 | 114 | 2021 |
Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0 ng/ml G Lucarelli, M Fanelli, AMV Larocca, CA Germinario, M Rutigliano, ... The Prostate 72 (15), 1611-1621, 2012 | 108 | 2012 |
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma G Lucarelli, M Rutigliano, M Ferro, A Giglio, A Intini, F Triggiano, ... Urologic Oncology: Seminars and Original Investigations 35 (7), 461. e15-461 …, 2017 | 102 | 2017 |
Complement Modulation of Anti‐Aging Factor Klotho in Ischemia/Reperfusion Injury and Delayed Graft Function G Castellano, A Intini, A Stasi, C Divella, M Gigante, P Pontrelli, R Franzin, ... American Journal of Transplantation 16 (1), 325-333, 2016 | 102 | 2016 |
PTX3 modulates the immunoflogosis in tumor microenvironment and is a prognostic factor for patients with clear cell renal cell carcinoma GS Netti, G Lucarelli, F Spadaccino, G Castellano, M Gigante, C Divella, ... Aging (Albany NY) 12 (8), 7585, 2020 | 100 | 2020 |
Microvascular density, macrophages, and mast cells in human clear cell renal carcinoma with and without bevacizumab treatment R Tamma, M Rutigliano, G Lucarelli, T Annese, S Ruggieri, E Cascardi, ... Urologic Oncology: Seminars and Original Investigations 37 (6), 355. e11-355 …, 2019 | 90 | 2019 |
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer M Ferro, MD Vartolomei, GI Russo, F Cantiello, ARA Farhan, ... World journal of urology 37, 507-514, 2019 | 89 | 2019 |
Renal Cell Carcinoma: A Study through NMR-Based Metabolomics Combined with Transcriptomics R Ragone, F Sallustio, S Piccinonna, M Rutigliano, G Vanessa, S Palazzo, ... Diseases 4 (1), 7, 2016 | 89 | 2016 |
Spondin-2, a secreted extracellular matrix protein, is a novel diagnostic biomarker for prostate cancer G Lucarelli, M Rutigliano, C Bettocchi, S Palazzo, A Vavallo, ... The Journal of urology 190 (6), 2271-2277, 2013 | 89 | 2013 |
Radiomics in prostate cancer: an up-to-date review M Ferro, O de Cobelli, G Musi, F del Giudice, G Carrieri, GM Busetto, ... Therapeutic Advances in Urology 14, 17562872221109020, 2022 | 86 | 2022 |
Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets NA di Meo, F Lasorsa, M Rutigliano, D Loizzo, M Ferro, A Stella, ... International Journal of Molecular Sciences 23 (22), 14360, 2022 | 85 | 2022 |
Delayed relief of ureteral obstruction is implicated in the long-term development of renal damage and arterial hypertension in patients with unilateral ureteral injury G Lucarelli, P Ditonno, C Bettocchi, G Grandaliano, L Gesualdo, ... The Journal of Urology, 2013 | 85 | 2013 |